Ligand Pharmaceuticals | LGND - Trade Creditors


Ligand Pharmaceuticals reported $37.11M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Agenus USD 71.08M 11.9M Mar/2026
Amgen USD 2.86B 16.65B Jun/2026
Anika Therapeutics USD 6.24M 103K Jun/2026
Arrowhead Research USD 27.78M 2.97M Jun/2026
Baxter International USD 1.03B 52M Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Enanta Pharmaceuticals USD 1.88M 63K Dec/2025
Enviri Corporation USD 257.33M 17.68M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Glaxosmithkline GBP 14.34B 6.39B Mar/2026
Heron Therapeutics USD 8.97M 24K Mar/2026
Insmed USD 74.55M 1.18M Jun/2026
Intrexon USD 4.85M 3.12M Jun/2024
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
Ligand Pharmaceuticals USD 37.11M 33.87M Mar/2026
MacroGenics USD 4.29M 500K Mar/2026
Merck USD 3.86B 541M Mar/2026
Pacira USD 17.51M 3.5M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Veracyte USD 8.02M 1.12M Jun/2026